Certara's change in inventory for the quarter that ended in Mar. 2026 was MXN0 Mil. It means Certara's inventory
stayed the same
from Dec. 2025 to Mar. 2026 .
Certara's change in inventory for the fiscal year that ended in Dec. 2025 was MXN0 Mil. It means Certara's inventory
stayed the same
from Dec. 2024 to Dec. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Certara's Days Inventory for the quarter that ended in Mar. 2026 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Certara's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.00.
Certara (MEX:CERT) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Certara's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Certara's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara Change In Inventory Related Terms
Certara Change In Inventory Historical Data
* Premium members only.
The historical data trend for Certara's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara (MEX:CERT) has a Change In Inventory of MXN0 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Certara and its competitors.
Is Certara's Change In Inventory too high?
Certara's current Change In Inventory is MXN0 Mil. Overall, Certara has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Certara's Change In Inventory compare to TALK and GDRX?
Certara's Change In Inventory of MXN0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Healthcare Providers & Services company?
A good Change In Inventory depends on the Healthcare Providers & Services industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Certara and its competitors. Certara's current Change In Inventory is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Certara (MEX:CERT) has a current Change In Inventory of MXN0 Mil. The stock's GF Value™ is MXN498.68, compared to a current price of MXN254.00 — trading 49.1% below its estimated fair value. The current Change In Inventory is MXN0 Mil. Certara's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Certara (MEX:CERT), the current Change In Inventory is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Certara (MEX:CERT) Overvalued in 2026?
Based on GuruFocus' analysis, Certara stock appears to be undervalued.
The current stock price of MXN254.00 is trading 49.1% below its estimated GF Value™ of MXN498.68.
Key valuation signals for MEX:CERT:
Change In Inventory: MXN0 Mil
GF Value™: MXN498.68 vs. price of MXN254.00 (49.1% below fair value)
No single metric tells the full story. See the MEX:CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
65GF Score
Get the complete analysis for MEX:CERT
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CERT has been successfully added to your 
